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Cognitive behaviour therapy for anxiety in psychosis: A 
systematic review and meta-analysis 
 
Abstract. 
Background: Anxiety is common in people with psychosis. Cognitive Behaviour 
Therapy (CBT) is an effective treatment for anxiety in people without psychosis. 
Given the prevalence of anxiety in those with psychosis, the efficacy of CBT in this 
population is important to consider. This review and meta-analysis therefore 
investigates the efficacy of CBT for anxiety in people with psychosis.  
Method: Twenty-nine studies were identified through systematic review, including 
controlled, uncontrolled and case report designs. Seventeen controlled and 
uncontrolled studies were included in the quantitative synthesis.  
Results: A medium, significant effect was found at post-treatment and follow-up 
when controlled and uncontrolled data were combined. For controlled between-groups 
data only, a small, significant effect was found at post-treatment and follow-up. The 
effect of CBT for anxiety on psychotic symptoms was investigated, resulting in a 
medium, significant effect for controlled and uncontrolled post-treatment data and a 
small, significant effect for controlled between-group data.  
Conclusions: CBT might have some effect in treating anxiety in people with 
psychosis. However, this review highlights a lack of scientifically rigorous studies in 
this area. Further research is required, including the use of well-designed randomised 
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Anxiety is common in people with psychosis, resulting in distress and poor clinical 
outcomes (Pallanti et al., 2004). Although anxiety may be understood as a response to 
the experience of psychosis, it can also predate psychosis and present as co-morbid 
conditions (Howells et al, 2017). Achim et al. (2011) found that 38.3% of individuals 
with schizophrenia also met criteria for at least one anxiety disorder. Rates varied, 
with social anxiety being the most prevalent at 14.9%, followed by post-traumatic 
stress disorder (PTSD; 12.4%) and obsessive compulsive disorder (OCD; 12.4%).  
The role of anxiety is highlighted in cognitive-behavioural models of 
psychosis. Garety et al. (2001) suggest that anxiety leads to a ‘search for meaning’ in 
relation to psychotic symptoms, resulting in interpretations associated with threat. In 
support, Freeman et al. (2002) note that psychological processes involved in anxiety, 
such as threat, are implicated in the content of persecutory delusions. In further 
support, Morrison’s (2001) model describes psychotic symptoms as ‘intrusions into 
awareness’ and argues that these intrusions are maintained by common anxiety 
processes, such as attentional bias, safety behaviours and thought suppression.       
Cognitive Behaviour Therapy (CBT) has been shown to be effective for 
anxiety in people without psychosis. In a meta-analysis of randomised placebo-





pooled effect size of 0.73 (95% confidence interval (CI), 0.88-1.65). Effect sizes 
ranged from 0.35 for panic disorder to 1.37 for OCD. More recently, Carpenter et al. 
(2018) found a pooled effect size of 0.56, with a small effect on quality of life 
(Hedges’ g = 0.30). As found by Hofmann and Smits (2008), the largest effects were 
found in studies of CBT for OCD (Hedges’ g = 1.13, 95% CI = 0.58-1.68, p < .001).  
Whilst systematic reviews and meta-analyses investigating CBT for different 
types anxiety have been conducted (e.g. OCD; Schirmbeck and Zink, 2013; Tundo 
and Necci, 2016; PTSD; Brand et al., 2017; Sin and Spain, 2016; Sin et al., 2017; 
Swan et al., 2017; social anxiety; Michail et al., 2017), no meta-analysis has explored 
the effectiveness of CBT across the range of anxiety presentations in people with 
psychosis. A number of systematic reviews have investigated CBT for anxiety in 
people with psychosis (Braga et al., 2013; Opoka and Lincoln, 2017; Opoka et al., 
2018). However, these include limited search strategies and omit relevant studies. The 
current study aims to extend and update these reviews and use a meta-analysis to 
explore the pooled effect size. Given the potential role of anxiety in psychosis, we are 




Protocol and registration  
The review was registered with the International Prospective Register of Systematic 







Search strategy  
Studies were identified via CINAHL Complete, MEDLINE (EBSCO), PsycINFO 
(EBSCO) and Web of Science. The Cochrane Database of Systematic Reviews, the 
UK Clinical Research (UKCRN) Study Portfolio and the ISRCTN Registry were also 
searched. Reference lists were scanned for studies not found electronically.  
Literature was searched from the date of inception until 12th November 2018. 
Automatic alerts were used to identify studies following the database search. The 
following search terms were used: cognitive behavio* (therap* OR treatment* OR 
intervention*) OR cognitive (therap* OR treatment* OR intervention*) OR behavio* 
(therap* OR treatment* OR intervention*) OR CBT AND psychosis OR psychotic 
OR schizo* OR hallucination* OR delusion* OR paranoi* AND anxi* OR OCD OR 
"obsessive-compulsive" OR obsession* OR compulsion* OR panic OR agoraphobi* 
OR "acute stress" OR PTSD OR "post-trauma*" OR "posttrauma*" OR GAD OR 
"general* anxi*" OR worr* OR phobi* OR "social* anxi*" OR "social* phobi*". 
 
Inclusion and exclusion criteria 
Studies were included in the review if they met the following criteria: (1) full text 
articles in English; (2) randomised controlled trials (RCTs), open trials and case 
reports; (3) investigating a type or component of CBT; (4) participants (all ages) with 
a diagnosis of psychosis (including an episode of psychosis, schizophrenia spectrum 
disorder or mood disorder with psychotic features) or clinically significant levels of 
psychotic symptoms; (5) participants with a diagnosis of anxiety (as per search terms 





‘severe mental illness’ samples, only data for participants with psychosis were 
included, when provided by the corresponding author(s). 
Exclusion criteria were as follows: (1) studies primarily focused on ‘at risk’ or 
‘ultra high risk’ populations; (2) investigation of stand-alone ‘third-wave’ 
interventions (e.g. compassion focused therapy, mindfulness); (3) anxiety was not the 
primary outcome measure; (4) no standardized measure of anxiety was used. Case 
reports were included in the review to provide an overview of the existing evidence 
base. However, they were not included in the quantitative synthesis. 
 
Risk of bias 
The Cochrane risk of bias tool (Higgins et al., 2011) was used to assess risk of bias 
within controlled and uncontrolled studies. A rating of ‘low’, ‘high’, or ‘unclear’ risk 
was provided for random sequence generation; allocation concealment; blinding of 
outcome assessors, incomplete outcome data; selective outcome reporting.  
 
Data analysis 
Comprehensive Meta-analysis 3.0 was used to analyse data from controlled and 
uncontrolled trials. Effect sizes (Hedges’ g), the 95% CI and p value were computed 
using means and standard deviations (SD), standard error or Cohen’s d. A random 
effects model was used to account for potential heterogeneity. 
The primary outcome was anxiety severity and the secondary outcome was 
psychotic symptom severity. For controlled trials, between-group post-treatment 
means and SD were used. For uncontrolled trials, pre-post means and SD were used. 





means and SD were also used for the treatment group for controlled trials. Pre-
treatment to follow-up and between-groups follow-up data (including follow-ups 
conducted up to six months post-treatment) were used to investigate treatment 
efficacy over time. Additional analyses were conducted for each type of anxiety using 
the pre-post data for all studies and between-group data for the controlled trials.   
Where repeated measures correlations were not available, a conservative 
estimate of 0.7 was used, as suggested by Rosenthal et al. (1993). Heterogeneity was 
assessed using I². As suggested by Higgins et al. (2003), an I² statistic of 25% or less 
was considered low, 50% was considered moderate and 75% was considered high. 
Publication bias was assessed by visual inspection of funnel plots and Fail-safe N.  
Where data were available, reliable and clinical change were calculated for 
anxiety and psychosis data in the case reports at post-treatment and (up to six months) 
follow-up using standardised formula (Jacobson et al., 1984; Jacobson and Truax, 
1991). As suggested by Wise (2004), outcomes were summarised as follows: reliable 
and clinical change (Recovered); reliable or clinical change (Improved); no reliable or 




Search results and study selection 
The study selection process is outlined in Figure 1. The initial search identified 4617 
papers, of which 1408 were duplicates. Twenty-nine studies were included in the 





synthesis. Secondary outcome data for van den Berg et al. (2015) was also included in 
the quantitative synthesis, extracted from de Bont et al. (2016). 
Some raw data for participants with psychosis from ‘severe mental illness’ 
samples were not suitable for inclusion due to insufficient participant numbers (Lu et 
al., 2012) or no information about diagnosis (Lu et al., 2009; Mueser et al., 2007; 
Rosenberg et al., 2004). Another study was excluded from the quantitative synthesis 
due to insufficient data to calculate effect size (Trappler and Newville, 2007). 
 
Study characteristics 
Study characteristics are outlined in Tables 1 and 2. Of the 29 studies included in the 
review, nine are controlled trials, eight are uncontrolled trials and 12 are case reports.  
The 17 studies in the quantitative synthesis involved 664 participants. The most 
studied type of anxiety was PTSD (n = 7), followed by social anxiety (n = 4), worry 
(n = 3), OCD (n = 1), panic disorder (n = 1) and anxiety (n = 1). For the controlled 
studies comparisons were typically made between CBT and treatment as usual (TAU) 
or wait-list (n = 8). One study (Mueser et al., 2015) compared CBT to a brief 
intervention including relaxation and psychoeducation. The 12 case reports included 
15 participants. Most reports investigated CBT for PTSD (n = 5), followed by OCD, 
(n = 3), social anxiety (n = 2), panic disorder (n = 1) and specific phobia (n = 1).  
Most studies used individual CBT (n = 22) but some used group CBT (n = 6). 
One study (Freuh et al., 2009) used both individual and group CBT (four vs. eight 
sessions). Treatment length varied from three (Hagen et al., 2014) to 66 sessions 
(Keen et al., 2017). Most studies (n = 22) used both cognitive and behavioural 





Prolonged Exposure (PE), two studies (Marcello et al., 2009; Mueser et al., 2015) 
used Cognitive Restructuring (CR), one study used written elaboration and CR 
(Kevan et al., 2007), one study used systematic desensitisation (Dudley et al., 2005) 
and one study used Exposure and Response Prevention (ERP; Ekers et al., 2004). 
Within a programme of CBT, two studies used Imagery Rescripting (ImRs; Callcott et 
al., 2004; Kayrouz et al., 2015) and one study used Virtual Reality (Gega et al., 2013).   
 
Risk of bias assessment 
Risk of bias assessment for the controlled and uncontrolled studies is displayed in 
Table 1. For the controlled studies, risk of bias was mostly low or unclear. Risk of 
bias varied across the uncontrolled studies, but was mostly high. 
 
Synthesis of results 
Effect size (Hedges’ g), the 95% CI, p values and I² for each of the outcomes are 
shown in Table 3. Forest plots are displayed in Figure 2.   
 
Primary outcomes 
A medium effect was found for the pre-post controlled and uncontrolled anxiety data. 
However, when only between-group controlled study data were included, a small 
effect was found. Heterogeneity was moderate to high for the pre-post data, but 
reduced to low to moderate when only between-group data were included.      
 Effect size for pre-post controlled and uncontrolled data ranged from medium 
for panic disorder to large for clinical anxiety. For between-group controlled data, 





medium effect was found for pre-post data and a small effect was found for between-
group data. Again, heterogeneity was moderate to high for pre-post data, but reduced 
to low to moderate when only between-group data were included.  
Secondary outcomes 
A medium effect was found for the pre-post controlled and uncontrolled psychosis 
data. When only the between-group controlled study data were included, a small 
effect was found. Heterogeneity was moderate to high for the pre-post data and low 
when only the between-groups data were included.  
 
Publication bias 
Visual inspection of funnel plots did not reveal significant asymmetry for anxiety. For 
anxiety at post-treatment for the pre-post data, Fail-safe N revealed that 1110 ‘null’ 
studies would be needed to bring the overall treatment effect to non-significance. 
However, for the between-group data, Fail-safe N revealed that only 19 ‘null’ studies 
would be needed to bring the overall treatment effect to non-significance.  
 
Discussion 
This review identifies 29 studies that investigate CBT for anxiety in psychosis, with a 
total of 679 participants. Controlled (n = 9) and uncontrolled (n = 8) studies and case 
reports (n = 12) were included to provide an overview of the evidence base. Overall, 
this work highlights the paucity of scientifically rigorous studies in this area. Of the 
29 studies included in the review, the following types of anxiety were represented: 
PTSD (n = 12); social anxiety (n = 6); worry (n = 3); OCD (n = 4), panic disorder (n = 





The quantitative synthesis resulted in a pre-post effect size of 0.74 and a between-
groups effect size of 0.35. The between-groups effect size is smaller than those 
reported in meta-analyses of CBT for anxiety in people without psychosis (i.e. 
Carpenter et al., 2018; Hedges’ g = 0.56; Hofmann and Smits, 2008; Hedges’ g = 
0.73). Although this suggests that CBT for anxiety is less effective in psychosis 
compared to those without psychosis, only a small number of between-groups studies 
were available. Although a larger effect size was found for pre-post data, high 
heterogeneity was found. This is expected given variation in methodology across 
studies, but suggests these data should be interpreted with caution.  
   
For psychotic symptoms, a medium effect size of 0.57 for pre-post data and a small 
effect size of 0.37 for between-group data was found. Although the latter finding 
suggests that CBT for anxiety only has a small effect on psychotic symptoms, a 
limited number of studies were used in the analysis (n = 6). As with the anxiety data 
heterogeneity was moderate to high for the pre-post data. Again, this is expected 
given varied methodology, but it should be considered in interpretation.  
Only 13 out of the 29 studies included in the review used measures of 
psychosis. Although the aim of the studies was not to target psychotic symptoms, 
including measures of psychosis is important. Omitting such measures means that the 
overall impact of CBT for anxiety in people with psychosis will not be clear.   
Limitations 
Despite a comprehensive review, only a small number of controlled studies were 
found. Most studies were uncontrolled trials or case reports, limiting the conclusions 





heterogeneity was found in the combined pre-post data and data for the different types 
of anxiety. Furthermore, only a small number of data were available for psychotic 
symptoms and follow-up.  
 
Future research 
Despite the prevalence and impact of anxiety in people with psychosis, the number of 
scientifically rigorous studies in this area is low. It is hoped that this work will 
encourage further research, including well-designed RCTs. The majority of studies 
identified investigated CBT for PTSD or social anxiety. It is hoped that interested 
researchers will investigate CBT for other types of anxiety in people with psychosis.  
 Interestingly, the between-groups effect size found in this meta-analysis is 
similar to the effect sizes found in meta-analyses investigating CBT for psychosis 
(e.g. Jauhar et al., 2014, 0.33; van der Gaag et al., 2014, 0.36 for delusions, 0.44 for 
hallucinations; Wykes et al., 2008, 0.40). It is possible that in people with psychosis 
CBT is as effective for anxiety as it is for psychotic symptoms. However, due to the 
lack of scientifically rigorous studies investigating CBT for anxiety in psychosis, this 
is not clear. Further research is required to gain a better understanding of the efficacy 
of CBT for anxiety in people with psychosis.  
 
Conclusion 
This is the first meta-analysis investigating CBT for anxiety in people with psychosis. 
The review provides an overview of the current evidence base, but in doing so 
highlights the paucity of scientifically rigorous studies in this area. Further research, 
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Table 1. Study characteristics (controlled and uncontrolled trials). 

























58 CBT  4 (*) TAU 16.7 PSWQ  
PSYRATS - 
delusions 




RCT 150 Schizophrenia/schizoaffective 




58 CBT 6 (5.5) TAU 6 PSWQ 
PSYRATS-
delusions 




RCT 16 Schizophrenia and social 
anxiety 
39.6 (*) 81.3 CBGT 8 (*) Waitlist 0 BSPS 1.5 U U U H L  
Kingsep et 
al. (2003) 
RCT  33 Schizophrenia and social 
anxiety 
* (*) 69.7 CBGT 13 (*) Waitlist  24.2 SIAS 2 U U L H L  
Isham et 
al. (2018) 
RCT 13 Schizophrenia-spectrum 
disorder and worry 
48.0 (*) * CBGT 8 (5.7) Waitlist 7.69 PSWQ 
PSYRATS - 
delusions 
1 U U H L L 
Mueser et 
al. (2008)e 
RCT 17 Schizophrenia/schizoaffective 
disorder and PTSD 
44.2 
(10.6) 






disorder and PTSD 
43.0 
(10.5) 











Steel et al. 
(2016) 
RCT 61 Schizophrenia/schizoaffective 
disorder and PTSD 
42.3 
(10.2) 
62.3 CBT 16 (12.3) TAU 23 CAPS-S 
PANSS 
(Positive) 
6 L L L H L  
van den 
berg et al. 
(2015) 
 
RCT 155 Schizophrenia 
spectrum/psychotic disorders 
and PTSD  
41.2 
(10.5) 
45.81 PE 8 (7.1) Waitlist 17.4 CAPS 
PSYRATS - 
delusions 




OT 8 Schizophrenia and panic 
disorder 
38 (*) 75 CBGT 16 (16) N/A 27.28 WASPA 0 H H H H L  
Freuh et 
al. (2009) 
OT 20 Schizophrenia/schizoaffective 
disorder and PTSD 
42.3 
(8.4) 




22 (17.1) N/A 35 CAPS 3 H H H H U  




6 Psychosis and social phobia * (*) 100 CBT with 
VR 
12 N/A 0 SIAS  
GPTS 




OT 34 Psychotic disorder/bipolar 
disorder or mood disorder 




88.2 PE 10-15 (7.2) N/A * CAPS 6 H H U H L  
Keen et al. 
(2017) 
OT 9 Psychosis and PTSD 37 
(11.3) 
56 CBT 25-66 (median 
= 41) 
N/A 22 PDS 
PSYRATS - 
delusions 
6 H H H L L  
Montreuil 
et al. 
OT 29 Psychosis (n = 23)/ARMS (n 
= 6) and social anxiety 
* (*) * CBGT 14 (12) N/A 10 SIAS 
SAPS 








OT 21 Schizophrenia/schizoaffective 
disorder and OCD 











OT 7 Psychosis and anxiety 25 (*) 57 CBGT 12 (12) N/A 0 DASS-21 3 H H H H L  
Note: * = data not available, ARMS = At-Risk Mental State; BSPS = Brief Social Phobia Scale, CAPS = Clinician Administered PTSD Scale, CAPS-S = Clinician Administered PTSD 
Scale for Schizophrenia, CBT = Cognitive behavioural therapy, CBGT = Cognitive behavioural group therapy, CR = Cognitive Restructuring, DASS-21 = Depression, Anxiety, Stress 
Scale – Short Form, GPTS = Green et al. Paranoid Thoughts Scale, H = High, L = Low, N/A = not applicable, OCD = obsessive compulsive disorder, OT = open trial, PANSS = 
Positive and Negative Syndrome Scale, PDS = Post-traumatic Diagnostic Scale, PE = Prolonged Exposure; PSYRATS = Psychotic Symptom Rating Scales, PSWQ = Penn State Worry 
Questionnaire, PTSD = post-traumatic stress disorder, RCT = randomised controlled trial, SAPS = Scale for the Assessment of Positive Symptoms, SIAS = Social Interaction Anxiety 
Scale, TAU = Treatment as usual, U = Unclear, VR = Virtual Reality, WASPA = Westergaard Assessment Scale for Panic Attacks, Y-BOCS = Yale-Brown Obsessive Compulsive 
Scale. 
a, b Whereby mean age and gender data presented for intervention and control group only, intervention data are used. 
c% attrition based on longest follow-up data available. 
























Table 2. Study characteristics (Case reports). 








Reliable change Outcome 
Callcott et al. 
(2004) 























Ekers et al. 
(2004) 
1 Schizophrenia and 
OCD 
31 M ERP 20 Y-BOCS 6 Yb Yb Recovered 
Good (2002) 1 Schizophrenia and 
social phobia 



















Gruber et al. 
(2006) 
 
1 Psychosis and panic 
disorder with 
agoraphobia  
* M CBT 19 BAI 
 
3 Yd Yd Recovered 








M CBT with ERP 3 Y-BOCS 
 




2 Bipolar with 
psychotic 
features/schizoaffectiv
43, 56 F, M CBT 16, 16 CAPS  
 







a and PTSD 






53 M CBT with ImRs 19 IES-R 
 
0 Y * Improved 
Kevan et al. 
(2007) 
1 Schizophrenia and 
PTSD 










Kobori et al.  
(2008) 








disorder and PTSD 
In 50’s M CR 16 PCL-S 
 














Note: * = data not available to calculate reliable and/or clinical change, BAI = Beck Anxiety Inventory, CAPS = Clinician Administered PTSD Scale, CBT = Cognitive Behavioural 
Therapy, CR = Cognitive Restructuring, ERP = Exposure and Response Prevention, F = female, IES = Impact of Events Scale, IES-R = Impact of Events Scale – Revised, IHS = 
Inventory of Hostility and Suspiciousness, ImRs = Imagery Rescripting, KGV = Krawiecka Goldberg Vaughan Scale, LSAS = Liebowitz Social Anxiety Scale, M = male, Mobility 
Inventory for Agoraphobia, MFQ = Modified Fear Questionnaire, N = No, N/A = Not applicable, OCD = obsessive compulsive disorder, PDS = Post-traumatic Diagnostic Scale, PCL-S 
= PTSD Checklist - Stressor specific version, PSYRATS = Psychotic Symptom Rating Scales, PTCI – Post-traumatic Cognitions Inventory, PTSD = post-traumatic stress disorder, 
SANS = Scale for the Assessment of Negative Symptoms, Y = Yes, Yale-Brown Obsessive Compulsive Scale. 
aOnly two cases used as the first participant did not have a diagnosis of psychosis. 
bClinical change significant only at six month follow-up and not post-treatment. 





dReliable and clinical change found at post-treatment and three month follow-up.  
eReliable and clinical change calculated from six-month follow-up data (post-treatment data not presented).  



















Table 3. Results from the quantitative synthesis. 
 






All studies Primary measure of anxiety 17 All studies 0.74 0.56, 0.92 <.001 73.25 
  All studies Positive psychotic symptoms 
 





0.57 0.36, 0.78 <.001 65.31 
  Type of anxiety PTSD 7 Frueh, Grubaugh, 
Keen, Mueser, 
Mueser, van den 
Berg, Steel 
0.70 0.37, 1.03 <.001 82.97 
   Social Anxiety/Social Phobia 4 Gega, Halperin, 
Kingsep, Montreuil 
0.71 0.39, 1.02 <.001 57.98 
   Worry/GAD 3 Foster, Freeman, 
Isham 
0.70 0.20, 1.20 .006 77.19 
   Panic 1 Arlow 0.66 0.12, 1.20 .017 0 
   OCD 1 Tundo 1.06 0.65, 1.46 <.001 0 
   Anxiety NOS 
 
1 Welfare-Wilson 1.14 0.46, 1.83 .001 0 
 Follow-up (1-
6 mths) 





Tundo, van den Berg 








Primary measure of anxiety 
 
9 All controlled 
studies 
0.35 0.07, 0.64 .015 46.91 
  All controlled 
studies 
Positive psychotic symptoms 
 
6 de Bont, Foster, 
Freeman, Isham, 
Mueser, Steel 





  Type of anxiety PTSD 4 Mueser, Mueser, van 
den Berg, Steel 
0.09 0.50, 0.67 .771 63.10 
   Social Anxiety/Social Phobia 2 Halperin, Kingsep 0.58 0.03, 1.14 .041 0 
   Worry/GAD 
 
3 Foster, Freeman, 
Isham 





Primary measure of anxiety 6 Foster, Freeman, 
Isham, Mueser, 
Steel, van den Berg 
0.34 0.05, 0.63 .022 40.88 
 
 
